Journal of Surgical Research
Volume 147, Issue 1 , Pages 75-78 , 1 June 2008

An Experimental Animal Model of Postobstructive Pulmonary Hypertension

  • Philipp Jungebluth
    • ,
  • Helmut Ostertag, M.D., Ph.D.
    • ,
  • Paolo Macchiarini, M.D., Ph.D.

      Affiliations

    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of General Thoracic Surgery, Hospital Clinico de Barcelona, University of Barcelona, c. Villarroel 170, E-08036 Barcelona, Spain.

Received 4 April 2007

References 

  1. Bresser P, Pepke-Zaba J, Jais X, et al. Medical therapies for chronic thromboembolic pulmonary hypertension: An evolving treatment paradigm. Proc Am Thorac Soc. 2006;3:594
  2. Mayer E, Klepetko W. Techniques and outcomes of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3:589
  3. Piovella F, D'Armini AM, Barone M, et al. Chronic thromboembolic pulmonary hypertension. Semin Thromb Hemost. 2006;32:848
  4. Porsolt RD, Le PM, Jalfre M. Depression: A new animal model sensitive to antidepressant treatments. Nature. 1977;266:730
  5. Fulton RM, Hutchinson EC, Jones AM. Ventricular weight in cardiac hypertrophy. Br Heart J. 1952;14:413
  6. Lang I, Kerr K. Risk factors for chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3:568
  7. Peacock A, Simonneau G, Rubin L. Controversies, uncertainties and future research on the treatment of chronic thromboembolic pulmonary hypertension. Proc Am Thorac Soc. 2006;3:608
  8. Rubin LJ, Hoeper MM, Klepetko W, et al. Current and future management of chronic thromboembolic pulmonary hypertension: From diagnosis to treatment responses. Proc Am Thorac Soc. 2006;3:601
  9. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004;23:637
  10. Dartevelle P, Fadel E, Mussot S, et al. [Surgical treatment of chronic thromboembolic pulmonary hypertension]. Presse Med. 2005;34:1475
  11. Doyle RL, McCrory D, Channick RN, et al. Surgical treatments/interventions for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126:63S
  12. Hoeper MM. Drug treatment of pulmonary arterial hypertension: current and future agents. Drugs. 2005;65:1337
  13. Kataoka M, Nagaya N, Satoh T, et al. A long-acting prostacyclin agonist with thromboxane inhibitory activity for pulmonary hypertension. Am J Respir Crit Care Med. 2005;172:1575
  14. Flox CA, Escribano SP, Tello de MR, et al. [Transition from prostacyclin to bosentan in five patients with severe pulmonary hypertension: The switch is possible]. Rev Esp Cardiol. 2006;59:737
  15. Minai OA, Arroliga AC. Long-term results after addition of sildenafil in idiopathic PAH patients on bosentan. South Med J. 2006;99:880
  16. Roman A, Gispert P, Monforte V, et al. [Long-term outcomes of treatment with bosentan in pulmonary hypertension]. Arch Bronconeumol. 2006;42:616
  17. Patterson KC, Weissmann A, Ahmadi T, et al. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med. 2006;145:152
  18. Jiang BH, Tawara S, Abe K, et al. Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol. 2007;49:85
  19. Sullivan CC, Du L, Chu D, et al. Induction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway. Proc Natl Acad Sci USA. 2003;100:12331
  20. Chu D, Sullivan CC, Du L, et al. A new animal model for pulmonary hypertension based on the overexpression of a single gene, angiopoietin-1. Ann Thorac Surg. 2004;77:449
  21. Tamesue K, Ichiba S, Nawa S, et al. An experimental study on pumpless extracorporeal membrane oxygenation (ECMO) support in a canine model. Acta Med Okayama. 2006;60:167
  22. Yaginuma G, Suzuki Y, Togo T, et al. [A new experimental model of pulmonary hypertension in dog using an adjustable pulmonary artery band]. Nippon Kyobu Geka Gakkai Zasshi. 1990;38:2194
  23. Ulku R, Eren NM, Cakir O, et al. [The effects of hypertonic NaCl (7.5%) in dogs with induced acute pulmonary artery obstruction]. Tuberk Toraks. 2003;51:145
  24. Faber MJ, Dalinghaus M, Lankhuizen IM, et al. Right and left ventricular function after chronic pulmonary artery banding in rats assessed with biventricular pressure-volume loops. Am J Physiol Heart Circ Physiol. 2006;291:H1580
  25. Cardoso PF, Hsieh CM, Daniel L, et al. Plasma atrial natriuretic factor concentrations in a canine model of right heart pressure overload. Clin Invest Med. 1991;14:310
  26. Kim H, Yung GL, Marsh JJ, et al. Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase. Exp Lung Res. 2000;26:287
  27. Okada K, Tanaka Y, Bernstein M, et al. Pulmonary hemodynamics modify the rat pulmonary artery response to injury (A neointimal model of pulmonary hypertension). Am J Pathol. 1997;151:1019

PII: S0022-4804(07)00648-8

doi: 10.1016/j.jss.2007.05.042

Journal of Surgical Research
Volume 147, Issue 1 , Pages 75-78 , 1 June 2008

Article Tools

* Image Usage & Resolution